Results 241 to 250 of about 49,543 (282)

BBK32 attenuates antibody-dependent complement-mediated killing of infectious Borreliella burgdorferi isolates. [PDF]

PLoS Pathog
Powell-Pierce AD, Booth CE, Smith PG, Shapiro BL, Allen SS, Garcia BL, Skare JT.   +6 more
europepmc   +1 more source

Hereditary angioedema: A national investigation of associated comorbidities and surgical procedures. [PDF]

World Allergy Organ J
Voloncs-Mindszenthy L, Horváth HR, Andrási N, Szilágyi T, Farkas H.   +4 more
europepmc   +1 more source

Complement proteins associated with circulatory and glomerular IgA-containing immune complexes in patients with IgA nephropathy. [PDF]

Sci Rep
Tsuji Y, Ohyama Y, Saitoh S, Enomoto T, Hirayama M, Yamaguchi H, Nishioka T, Mizuno T, Tsuboi N, Novak J, Takahashi K.   +10 more
europepmc   +1 more source

Complement C1 inhibitor protein

Reactions Weekly, 2012
&NA;
  +7 more sources

Complement C1 inhibitor protein

Reactions Weekly, 2015

  +5 more sources

Complement-c1-inhibitor protein

Reactions Weekly, 2018

  +5 more sources

Complement-C1 inhibitor protein

Reactions Weekly, 2019

  +5 more sources

Factor J, a human inhibitor of complement C1, is a cationic, highly glycosylated protein

Immunology Letters, 1994
Factor J (FJ) is a new inhibitor of the complement system. This work supports the fact that FJ is a cationic molecule (pI > or = 9.6 in native conditions, or pI = 8.1 in denaturing conditions) with a high sugar content (40%) that is able to interact with different lectins, suggesting a complex glycosylation.
Miguel Ángel Jiménez‐Clavero, Carolina González-Rubio, Gumersindo Fontán, Margarita López‐Trascasa   +3 more
openalex   +3 more sources